Judge Dismisses AstraZeneca’s Challenge to Medicare Drug Price Negotiation

A federal judge in Delaware on Friday denied AstraZeneca’s lawsuit challenging the constitutionality of Medicare’s drug price negotiation program, citing the company’s lack of legal standing. In his March 1 ruling, U.S. District Judge Colm Connolly stated that the pharmaceutical company lacked standing to challenge the guidance issued by Medicare to implement the program. The judge also stated that AstraZeneca failed to identify any property interest protected by the constitution that is put in jeopardy by the program. “AstraZeneca does not say or suggest in any way how its decision-making about other drugs has been or could be negatively affected by the Guidance,” Mr. Connolly stated....